Clinical Trial Update: A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial protocol evaluating the DIA:CONN P8 Smart Insulin Pen with CGM-based coaching for Type 1 and Type 2 diabetes; the study is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIA:CONN P8 Smart Insulin Pen with CGM-Based Coaching (DIA:CONN P8 Smart Insulin Pen)

Snippet

Sponsor: G2e Co., Ltd | Conditions: Diabetes Mellitus | NA | Status: NOT_YET_RECRUITING